Roche expands, adds jobs

Share this article:

Roche is taking on 500 new employees and is expanding its production capacity. The Swiss drug maker announced Monday that it was investing a total of $800 million across four locations over the next five years.

The company said in a statement that the expansions in Penzburg, Germany; Basel, Switzerland; and Vacaville and Oceanside, CA, are part of an efforts to support demand for biologics, such as Perjeta, as well as the antibody drug conjugate Kadcyla.

This may sound familiar: AstraZeneca announced Tuesday that, it, too was diving deeper into antibody drug conjugates through an acquisition and by purchasing an equity stake in an ADC-focused company.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.